Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000016

CEO bought 46,500 shares at an average $0.02 ($966)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

13 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-27 Purchase : show line 1 in the form +5,000 $0.02 $99 21,648,123 D
2019-02-27 Purchase : show line 2 in the form +500 $0.02 $10 21,648,623 D
2019-02-27 Purchase : show line 3 in the form +450 $0.02 $9 21,649,073 D
2019-02-27 Purchase : show line 4 in the form +50 $0.02 $1 21,649,123 D
2019-02-27 Purchase : show line 5 in the form +500 $0.02 $10 21,649,623 D
2019-02-27 Purchase : show line 6 in the form +5,000 $0.02 $100 21,654,623 D
2019-02-27 Purchase : show line 7 in the form +5,000 $0.02 $106 21,659,623 D
2019-02-27 Purchase : show line 8 in the form +5,000 $0.02 $105 21,664,623 D
Open-market purchases · 46,500 sh · avg $0.02 · $966
Loading xslF345X03/primary_doc.xml…